-
1 Comment
Surgalign Holdings, Inc is currently in a long term downtrend where the price is trading 37.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.6.
Surgalign Holdings, Inc's total revenue sank by 67.4% to $26M since the same quarter in the previous year.
Its net income has increased by 49.6% to $-100M since the same quarter in the previous year.
Finally, its free cash flow fell by 2975.4% to $-16M since the same quarter in the previous year.
Based on the above factors, Surgalign Holdings, Inc gets an overall score of 2/5.
ISIN | None |
---|---|
Industry | Medical Devices |
Sector | Healthcare |
CurrencyCode | EUR |
Exchange | F |
Target Price | 3.36 |
---|---|
Dividend Yield | 0.0% |
PE Ratio | None |
Market Cap | 39M |
Beta | 2.11 |
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RT2.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024